Tybourne Capital Management as of Sept. 30, 2025
Portfolio Holdings for Tybourne Capital Management
Tybourne Capital Management holds 4 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Taysha Gene Therapies Com Shs (TSHA) | 39.1 | $12M | 3.7M | 3.27 | |
| Forte Biosciences Com New (FBRX) | 38.1 | $12M | 787k | 15.00 | |
| Alumis (ALMS) | 18.0 | $5.6M | 1.4M | 3.99 | |
| Zentalis Pharmaceuticals (ZNTL) | 4.7 | $1.5M | 962k | 1.51 |
